Drug‐induced liver injury ( DILI ) ascribed to non‐steroidal anti‐inflammatory drugs ( NSAIDs ) in the USA —Update with genetic correlations
Liver International · 2024
DOI: 10.1111/liv.15892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2024. Verfasst von Herbert L Bonkovsky und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Wake Forest University School of Medicine and Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, USA. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Chemical and Drug Induced Liver Injury, Diclofenac. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCRR NIH HHS, NIDDK, NIDDK NIH HHS.
Abstract (Originalsprache)
Objective
To describe patients with NSAID‐DILI, including genetic factors associated with idiosyncratic DILI.
Methods
In DILIN, subjects with presumed DILI are enrolled and followed for at least 6 months. Causality is adjudicated by a Delphic approach. HLA sequencing of multiethnic NSAID‐DILI patients and HLA allele imputation of matching population controls were performed following overall, class and drug‐based association analysis. Significant results were tested in a non‐Hispanic White (NHW) case–control replication cohort.
Results
Between September 2004 and March 2022, causality was adjudicated in 2498, and 55 (41 [75%] women) were assessed as likely due to NSAIDs. Median age at onset was 55 y (range 22–83 y). Diclofenac was the causative drug in 29, celecoxib in 7, ibuprofen in 5, etodolac and meloxicam each in 4. Except for meloxicam and oxaprozin ( n = 2), the liver injury was hepatocellular with median R 15–25. HLA‐DRB1*04:03 and HLA‐B*35:03 were significantly more frequent in NSAID‐DILI patients than in non‐NSAID DILI controls. Interestingly, 85% of the HLA‐DRB1*04:03 carriers developed DILI due to the use of acetic acid derivative NSAIDs, supporting the hypothesis that HLA‐DRB1*04:03 could be a drug and/or class risk factor. HLA‐B*35:03 but not HLA‐DRB1*04:03 association was confirmed in the independent NHW replication cohort, which was largely driven by diclofenac.
Conclusions
Despite prevalent use, NSAID‐DILI is infrequent in the United States. Diclofenac is the most commonly implicated, and adherence to warnings of risk and close observation are recommended. The increased frequency of HLA‐B*35:03 and DRB1*04:03 , driven by diclofenac, suggests the importance of immune‐mediated responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Wake Forest University School of Medicine and Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, USA.
- Department of Internal Medicine, Indiana University School of Medicine and IU Hospital, Indianapolis, Indiana, USA.
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Duke Molecular Physiology Institute, Durham, North Carolina, USA.
- Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
- Department of Biostatistics and Bioinformatics, Duke Clinical Research Institute, Durham, North Carolina, USA.
ORCID-Profile: Herbert L Bonkovsky, Marwan Ghabril, Robert J Fontana, David E Kleiner
Förderung
- NCRR NIH HHS
- NIDDK
- NIDDK NIH HHS
- NCATS NIH HHS
- NHGRI NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Bonkovsky, H. L., Ghabril, M., Nicoletti, P., Dellinger, A., Fontana, R. J., Barnhart, H., Gu, J., Daly, A. K., Aithal, G. P., Phillips, E. J., Kleiner, D. E., & US DILIN Investigators (2024). Drug‐induced liver injury ( DILI ) ascribed to non‐steroidal anti‐inflammatory drugs ( NSAIDs ) in the USA —Update with genetic correlations. Liver International. https://doi.org/10.1111/liv.15892
Vancouver
Bonkovsky HL, Ghabril M, Nicoletti P, Dellinger A, Fontana RJ, Barnhart H, et al. Drug‐induced liver injury ( DILI ) ascribed to non‐steroidal anti‐inflammatory drugs ( NSAIDs ) in the USA —Update with genetic correlations. Liver International. 2024. doi:10.1111/liv.15892
BibTeX
@article{Bonkovsky2024,
author = {Bonkovsky, Herbert L and Ghabril, Marwan and Nicoletti, Paola and Dellinger, Andrew and Fontana, Robert J and Barnhart, Huiman and Gu, Jiezhun and Daly, Ann K and Aithal, Guruprasad P and Phillips, Elizabeth J and Kleiner, David E and US DILIN Investigators, US DILIN Investigators},
title = {Drug‐induced liver injury ( DILI ) ascribed to non‐steroidal anti‐inflammatory drugs ( NSAIDs ) in the USA —Update with genetic correlations},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.15892}
}
EUVIMED